Testosterone Replacement With Transdermal Therapeutic Systems
- 5 May 1989
- journal article
- research article
- Published by American Medical Association (AMA)
- Vol. 261 (17), 2525-2530
- https://doi.org/10.1001/jama.1989.03420170069032
Abstract
Testosterone was administered transdermally to hypogonadal men under three protocols. In the first protocol, it was shown that peak levels of testosterone were achieved three to eight hours after scrotal application of a transdermal therapeutic system containing 5, 10, or 15 mg of testosterone, and values at 22 hours were greater than 60% of peak values. In the second protocol, patients were treated with 10-mg systems for four weeks followed by 15-mg systems for eight weeks. Serum samples were obtained three to five hours after application of the transdermal therapeutic system. Testosterone increased from a pretreatment level (mean ± SE) of 1.5 ± 0.4 nmol/L to 15.2 ±3.4 nmol/L at four weeks, 18.6 ± 3.3 nmol/L at eight weeks, and 17.3 ± 2.8 nmol/L at 12 weeks. The serum testosterone/dihydrotestosterone (DHT) ratio fell from 4.53 to 2.47 at four weeks and was similar at eight and 12 weeks, reflecting a greater rise in DHT with this route of treatment (normal testosterone/DHT ratio, 9/1 to 12/1). Eight patients were treated with the 15-mg systems for an additional year. Seven of the eight were compliant and maintained serum testosterone levels (at six time points from two to 12 months [mean ± SE]) ranging from 11.5 ±1.2 to 44.9 ±2.4 nmol/L. It was possible to achieve physiological serum levels of testosterone by transdermal administration of testosterone in two thirds of our hypogonadal men. (JAMA. 1989;261:2525-2530)Keywords
This publication has 15 references indexed in Scilit:
- Loss of Circadian Rhythmicity in Blood Testosterone Levels with Aging in Normal Men*Journal of Clinical Endocrinology & Metabolism, 1983
- Absorption, Metabolism, and Excretion of Oral Testosterone in Humans by Mass FragmentographyJournal of Clinical Endocrinology & Metabolism, 1980
- Treatment of Male Hypogonadism with Testosterone Enanthate*Journal of Clinical Endocrinology & Metabolism, 1980
- Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patientsJournal of Endocrinological Investigation, 1980
- Comparison of Testosterone, Dihydrotestosterone, Luteinizing Hormone, and Follicle-Stimulating Hormone in Serum after Injection of Testosterone Enanthate or Testosterone CypionateFertility and Sterility, 1980
- Gonadotropin Suppression in Normal Males and Males with 1° Hypogonadism: Evaluation of Four AndrogensInternational Journal of Andrology, 1978
- THERAPEUTIC EFFECTIVENESS OF ORAL TESTOSTERONEThe Lancet, 1974
- A Simplified Method for the Quantitative Determination of Testosterone-Estradiol-Binding Globulin Activity in Human PlasmaJournal of Clinical Endocrinology & Metabolism, 1972
- Radioimmunoassay of plasma estrogensSteroids, 1971
- PLASMA TESTOSTERONE VALUES IN DIFFERENT FORMS OF TESTOSTERONE TREATMENTActa Endocrinologica, 1969